Situation: Our client wanted to increase their appeal and value to payers by developing innovative therapeutic category cost management strategies. The client also wanted to prepare the market for new product launches that would benefit from continued open access in the category.
CRA contribution: Market research with KOLs in the payer community allowed CRA to identify key payer concerns and unmet needs, which ultimately informed a comprehensive category management approach that AEs could take to their customers.
Result: CRA delivered innovative management solutions to payer customers, encouraging payers to focus on greatest opportunities for cost savings rather than short-term gains from higher rebates.
Looking under the hood: UK economic outlook and implications
2021 was expected to be a year of recovery and growth – both globally and in the UK. However, as we are now in a race between a more infectious virus strain...